glp-1 vs glp-3 How GLP-1, GLP-2, and support weight loss differently GLP-1 vs. GLP-2 vs. GLP-3:
Description
Injection site reactions like redness, itching, or swelling occur occasionally with both medications but rarely require stopping treatment
Weight-loss GLP-1s (Wegovy, Zepbound) are often denied because most insurers do not cover weight-loss treatments , despite obesity being a recognized medical condition

The medication has a long half-life that provides consistent blood levels throughout the week regardless of injection time

This information is essential to encourage payers to expand access to these medications earlier in the course of diabetes and irrespective of HbA 1c levels

Considerations ESG weight loss is moderate compared to surgery

95% CI 1.59, 0.65), metformin (WMD: 1.09